Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amcal is a long-established Australian community pharmacy brand that provides prescription dispensing, over-the-counter medicines, vaccinations, medication reviews, health screening, and broader health and wellness products and services. The brand traces its origins to 1937 as Allied Master Chemists of Australia Limited and today operates as one of Australia’s best-known pharmacy networks. Amcal is part of Sigma Healthcare’s retail pharmacy portfolio and is positioned as a national health destination brand serving consumers through locally operated pharmacies across Australia. It is healthcare-related, but it is not a biotech or drug-development company and does not have a therapeutic R&D pipeline in the conventional pharma sense. Its business is centered on pharmacy retail, patient services, and community-based healthcare access rather than discovery, clinical development, or proprietary therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amcal.